HCL bags $500 million deal from pharma giant MSD

Noida, May 5: IT major HCL Technologies Ltd (HCL) has bagged a 500 million dollars-worth five-year IT management deal with the pharmaceutical giant MSD.

With this deal HCL has only managed to extend its long-term relationship with MSD or Merck & Co, Inc, headquarterd in Whitehouse Station, NJ, USA.

HCL, which has been working with MSD since 2004, has become an integral business & technology services partner to the global research-driven pharmaceutical company.

The IT services provider has been providing a multitude of services including software-led IT solutions, remote infrastructure management, engineering and business and knowledge process services to MSD, HCL said in a statement announcing the deal.

"For five years, MSD has leveraged HCL"s extensive expertise in life sciences and healthcare to streamline operational efficiencies and consolidate its IT portfolio," said Richard G Branton, Vice President of Application Services, MSD.

Dubbing the deal a 'landmark win for HCL', Shami Khorana, president HCL Americas, said, “We are committed to creating transformational value for MSD in this engagement and we look forward to playing a key role in the organization"s growth across global markets."

OneIndia News